N/aa |
AUT1 |
1311136-84-1 |
HS-10296 |
阿美替尼 |
1899921-05-1 |
BAY-1251152 |
1610358-56-9 |
1610358-56-9 |
VL285 |
VL285 |
1448188-57-5 |
Budesonide Impurity 7 |
布地奈德杂质7 |
3949-79-9 |
AWZ1066S |
AWZ1066S |
2239272-16-1 |
2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
2-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzo[4,5]imidazo[1,2-a][1,8]naphthyridine-6-carbonitrile |
1822358-25-7 |
tris-para-bromophenylphosphane |
三(4-溴苯基)膦 |
29949-81-3 |
SW-100 |
SW-100 |
2126744-35-0 |
Enrofloxacin EP Impurity E |
恩诺沙星EP杂质E |
1369495-59-9 |
CBP-IN-1 |
CCS1477 |
2222941-37-7 |
Kinase inhibitor-1 |
Kinase inhibitor-1 |
2135696-72-7 |
Apixaban Related Compound 3 |
5-氯,4-甲基戊酰氯 |
813452-05-0 |
1,3-Propanediol, 2,2-didecyl- |
1,3-Propanediol, 2,2-didecyl- |
170025-81-7 |
NUC-3373 |
NUC-3373 |
1332837-31-6 |
Zotatifin |
Zotatifin |
2098191-53-6 |
iGOT1-01 |
化合物IGOT1-01 |
882256-55-5 |
BMS-P5 |
BMS-P5 |
1550371-22-6 |
ABT-263-piperazine |
ABT-263-piperazine |
2143096-93-7 |
Spesolimab |
司柏索利单抗 |
2097104-58-8 |